Propanc Biopharma, Inc. (PPCB)
Score window: May. 30, 2025 to May. 29, 2026
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Apr. 16, 2026 | CORRESP | Neutral/Informational | Moderate | Propanc Biopharma, Inc. has submitted a request to the SEC to expedite the effectiveness of their Registration Statement on Form S-1, originally filed on April 10, 2026. They are … | Read Filing EDGAR |
| Apr. 15, 2026 | UPLOAD | Neutral/Informational | Low | The SEC has notified Propanc Biopharma, Inc. that it will not review their registration statement filed on April 10, 2026. The correspondence emphasizes that the responsibility fo… | Read Filing EDGAR |
| Feb. 20, 2026 | CORRESP | Neutral/Informational | Moderate | Propanc Biopharma, Inc. has submitted a request to the SEC for the effectiveness of their Registration Statement on Form S-1, which was filed on February 19, 2026. They are seekin… | Read Filing EDGAR |
| Feb. 12, 2026 | CORRESP | Neutral/Informational | Low | Propanc Biopharma, Inc. has formally requested the withdrawal of its previous request for the acceleration of the effectiveness of its Registration Statement on Form S-1, which wa… | Read Filing EDGAR |
| Feb. 10, 2026 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to Propanc Biopharma, Inc. that it will not review the company's registration statement filed on February 2, 2026. The letter emphasizes that the responsi… | Read Filing EDGAR |
| Feb. 10, 2026 | CORRESP | Neutral/Informational | Moderate | Propanc Biopharma, Inc. has submitted a request to the SEC for the effectiveness of their Registration Statement on Form S-1, which was filed on February 2, 2026. They are seeking… | Read Filing EDGAR |
| Aug. 12, 2025 | CORRESP | Neutral/Informational | Moderate | Propanc Biopharma, Inc. has submitted a request to the SEC for the effectiveness of their Amended Registration Statement on Form S-1, which was filed on May 30, 2025. They are see… | Read Filing EDGAR |
| Aug. 12, 2025 | CORRESP | Neutral/Informational | Moderate | The correspondence from Propanc Biopharma, Inc. to the SEC is a request for the acceleration of the effective date of their Registration Statement on Form S-1. The request is made… | Read Filing EDGAR |
| Jul. 31, 2025 | CORRESP | Neutral/Informational | Moderate | The correspondence from Propanc Biopharma, Inc. to the SEC is a request for the acceleration of the effective date of their Registration Statement on Form S-1. The request is made… | Read Filing EDGAR |
| Jul. 31, 2025 | CORRESP | Neutral/Informational | Moderate | Propanc Biopharma, Inc. has submitted a request to the SEC for the effectiveness of their Amended Registration Statement on Form S-1, which was filed on May 30, 2025. They are see… | Read Filing EDGAR |
| Jul. 29, 2025 | CORRESP | Neutral/Informational | Low | Propanc Biopharma, Inc. has formally requested the withdrawal of its previous request for the acceleration of the effectiveness of its Registration Statement on Form S-1. Initiall… | Read Filing EDGAR |
| Jul. 29, 2025 | CORRESP | Neutral/Informational | Low | Propanc Biopharma, Inc. has formally requested the withdrawal of its previous request for the acceleration of the effectiveness of its Registration Statement on Form S-1. Initiall… | Read Filing EDGAR |
| Jul. 24, 2025 | CORRESP | Neutral/Informational | Moderate | The correspondence from Propanc Biopharma, Inc. to the SEC is a request for the acceleration of the effective date of their Registration Statement on Form S-1. The request is made… | Read Filing EDGAR |
| Jul. 24, 2025 | CORRESP | Neutral/Informational | Low | Propanc Biopharma, Inc. has submitted a request to the SEC for the effectiveness of their Amended Registration Statement on Form S-1, which was filed on May 30, 2025. They are see… | Read Filing EDGAR |